Economic evaluation of treatment with orlistat in Italian obese patients

By Iannazzo S.   Zaniolo O.   Pradelli L.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 63-74

Informa Healthcare

Access to resources Recommend Favorite

Effect of orlistat, micronised fenofibrate and their combination on metabolic parameters in overweight and obese patients with the metabolic syndrome: the FenOrli study

By Filippatos T. D.   Kiortsis D. N.   Liberopoulos E. N.   Georgoula M.   Mikhailidis D. P.   Elisaf M. S.  

Current Medical Research and Opinion, Vol. 21, Iss. 12, 2005-12 ,pp. : 1997-2006

Informa Healthcare

Access to resources Recommend Favorite

The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia

By Nakou E. S.   Filippatos T. D.   Georgoula M.   Kiortsis D. N.   Tselepis A. D.   Mikhailidis D. P.   Elisaf M. S.  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1919-1929

Informa Healthcare

Access to resources Recommend Favorite

An update on serum amyloid A-LDL and its potential use for dyslipidemic patients receiving lipid-modulating treatment

By Kotani Kazuhiko  

Clinical Lipidology, Vol. 8, Iss. 4, 2013-08 ,pp. : 419-423

Future Medicine

Access to resources Recommend Favorite

Effect of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes mellitus: a systematic review and meta‐analysis of randomized controlled trials

By  

OBESITY REVIEWS, Vol. 16, Iss. 12, 2015-12 ,pp. : 1071-1080

John Wiley & Sons Inc

Access to resources Recommend Favorite